A detailed history of Pinnacle Financial Partners Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 4,899 shares of NVO stock, worth $680,324. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,899
Previous 3,524 39.02%
Holding current value
$680,324
Previous $364,000 72.8%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $140,401 - $186,889
1,375 Added 39.02%
4,899 $629,000
Q4 2023

Jan 22, 2024

BUY
$87.78 - $105.45 $309,336 - $371,605
3,524 New
3,524 $364,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $313B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.